Moxifloxacin Suppliers & Bulk Manufacturers
Available Forms: IV Infusion
Available Strengths: 400 mg/250 mL
Reference Brands: Avelox®, Avalox®(EU); Avelox®, Vigamox®(US)
Category: Respiratory Disorder
Moxifloxacin is a broad-spectrum fluoroquinolone antibiotic used for respiratory, sinus, and skin infections. Available in the US and EU as 400 mg tablets, IV infusion, and 0.5% eye drops, it's sold under brands like Avelox® and Vigamox®. Ideal for B2B, PCD, and global pharma markets. Moxifloxacin is available in IV Infusion and strengths such as 400 mg/250 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Moxifloxacin is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Moxifloxacin can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Moxifloxacin is a fourth-generation fluoroquinolone antibiotic used to treat respiratory tract infections, sinusitis, skin infections, and intra-abdominal infections. It is available in the US and EU in multiple forms including 400 mg tablets, 400 mg/250 mL IV infusion, and 0.5% ophthalmic solution. Marketed under brand names such as Avelox®, Avalox®, and Vigamox®, Moxifloxacin is known for its once-daily dosing, excellent tissue penetration, and broad-spectrum antibacterial activity. Widely prescribed for both inpatient and outpatient care, it is a top product for B2B pharma, PCD franchise, and international export, serving as a critical antibiotic in global healthcare supply chains.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Ensifentrine
Strength:
3 mg per 2.5 mL
Form: Inhalation solution
Reference Brands: Ohtuvayre (USA)
View DetailsMepolizumab
Strength:
100 mg/1 mL
Form: injection (prefilled syringe)
Reference Brands: Nucala (USA/EU)
View DetailsLevalbuterol
Strength:
0.31 mg, 0.63 mg, 1.25 mg
Form: Inhalation solution
Reference Brands: Xopenex (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers